134 related articles for article (PubMed ID: 8946929)
21. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
[TBL] [Abstract][Full Text] [Related]
23. Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB-1) in childhood acute lymphoblastic leukaemia.
Sauerbrey A; Stammler G; Zintl F; Volm M
Br J Haematol; 1996 Jul; 94(1):99-104. PubMed ID: 8757515
[TBL] [Abstract][Full Text] [Related]
24. P-glycoprotein expression in patients with acute leukemia-clinical relevance.
Nüssler V; Pelka-Fleischer R; Zwierzina H; Nerl C; Beckert B; Gieseler F; Diem H; Ledderose G; Gullis E; Sauer H; Wilmanns W
Leukemia; 1996 Jul; 10 Suppl 3():S23-S31. PubMed ID: 8656697
[TBL] [Abstract][Full Text] [Related]
25. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
Hof J; Krentz S; van Schewick C; Körner G; Shalapour S; Rhein P; Karawajew L; Ludwig WD; Seeger K; Henze G; von Stackelberg A; Hagemeier C; Eckert C; Kirschner-Schwabe R
J Clin Oncol; 2011 Aug; 29(23):3185-93. PubMed ID: 21747090
[TBL] [Abstract][Full Text] [Related]
26. [Clinical characteristics and outcomes of 59 patients with acute lymphoblastic leukemia positive for BCR/ABL].
Liu Z; Liu XL; Du QF; Xu N; Zhong M; Song LL; Yi ZS; Liu QF; Meng FY; Zhou SY
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):512-5. PubMed ID: 19304540
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.
Burke L; Flieder DB; Guinee DG; Brambilla E; Freedman AN; Bennett WP; Jones RT; Borkowski A; Caporaso NA; Fleming M; Trastek V; Pairolero P; Tazelaar H; Midthun D; Jett JR; Liotta LA; Travis WD; Harris CC
Clin Cancer Res; 2005 Jan; 11(1):232-41. PubMed ID: 15671551
[TBL] [Abstract][Full Text] [Related]
28. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
[TBL] [Abstract][Full Text] [Related]
29. Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction.
Radich JP; Kopecky KJ; Boldt DH; Head D; Slovak ML; Babu R; Kirk J; Lee A; Kessler P; Appelbaum F
Leukemia; 1994 Oct; 8(10):1688-95. PubMed ID: 7934164
[TBL] [Abstract][Full Text] [Related]
30. Expression of p53 and retinoblastoma gene in high-grade nodal peripheral T-cell lymphomas: immunohistochemical and molecular findings suggesting different pathogenetic pathways and possible clinical implications.
Pescarmona E; Pignoloni P; Santangelo C; Naso G; Realacci M; Cela O; Lavinia AM; Martelli M; Russo MA; Baroni CD
J Pathol; 1999 Aug; 188(4):400-6. PubMed ID: 10440751
[TBL] [Abstract][Full Text] [Related]
31. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
[TBL] [Abstract][Full Text] [Related]
32. Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial.
Martino R; Bellido M; Brunet S; Altés A; Sureda A; Guárdia R; Aventín A; Nomdedéu JF; Domingo-Albós A; Sierra J
Haematologica; 1999 Jun; 84(6):505-10. PubMed ID: 10366793
[TBL] [Abstract][Full Text] [Related]
33. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T
Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210
[TBL] [Abstract][Full Text] [Related]
34. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma.
Naka T; Toyota N; Kaneko T; Kaibara N
Anticancer Res; 1998; 18(1B):555-64. PubMed ID: 9568177
[TBL] [Abstract][Full Text] [Related]
35. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.
Preudhomme C; Dervite I; Wattel E; Vanrumbeke M; Flactif M; Lai JL; Hecquet B; Coppin MC; Nelken B; Gosselin B
J Clin Oncol; 1995 Apr; 13(4):812-20. PubMed ID: 7707106
[TBL] [Abstract][Full Text] [Related]
37. Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia.
Stock W; Tsai T; Golden C; Rankin C; Sher D; Slovak ML; Pallavicini MG; Radich JP; Boldt DH
Blood; 2000 Apr; 95(7):2364-71. PubMed ID: 10733508
[TBL] [Abstract][Full Text] [Related]
38. Expression of differentially phosphorylated Rb and mutant p53 proteins in myeloid leukemia cell lines.
Sen S; Takahashi R; Rani S; Freireich EJ; Stass SA
Leuk Res; 1993 Aug; 17(8):639-47. PubMed ID: 8355507
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia.
Marks DI; Kurz BW; Link MP; Ng E; Shuster JJ; Lauer SJ; Carroll D; Brodsky I; Haines DS
J Clin Oncol; 1997 Mar; 15(3):1158-62. PubMed ID: 9060559
[TBL] [Abstract][Full Text] [Related]
40. Frequency and prognostic significance of murine double minute protein-2 overexpression and p53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Hematology; 2009 Dec; 14(6):335-40. PubMed ID: 19941740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]